Modeling the Interaction of Low Molecular Weight Targeting Ligands and Synthesis of Lipotripeptides with Potential Inhibitory Ability Against Integrin αVβ3

IF 0.7 Q4 CHEMISTRY, MULTIDISCIPLINARY
A. Yu. Mikhailova, U. A. Budanova, Yu. L. Sebyakin
{"title":"Modeling the Interaction of Low Molecular Weight Targeting Ligands and Synthesis of Lipotripeptides with Potential Inhibitory Ability Against Integrin αVβ3","authors":"A. Yu. Mikhailova,&nbsp;U. A. Budanova,&nbsp;Yu. L. Sebyakin","doi":"10.3103/S0027131423020050","DOIUrl":null,"url":null,"abstract":"<p>Low molecular weight RGD peptides and RGD mimetics are widely studied as ligands targeting the corresponding receptor in the diagnosis and therapy of cancer, as well as in the field of bone tissue regeneration. Some of them are undergoing preclinical trials. The aim of this study is to select the optimal variants of the ligand structure based on an aliphatic RGD mimetic. By methods of molecular modeling (blind docking and active site docking), the most advantageous constructions for the formation of a stable complex with the integrin α<sub>V</sub>β<sub>3</sub> are determined. A scheme is developed and two lipotripeptides Gnd-GABA-Gly-Asp(C<sub>16</sub>)<sub>2</sub> and Gnd-β-Ala-Gly-Asp(C<sub>16</sub>)<sub>2</sub> with the potential ability to inhibit this receptor on the surface of tumor tissues are synthesized.</p>","PeriodicalId":709,"journal":{"name":"Moscow University Chemistry Bulletin","volume":"78 2","pages":"55 - 62"},"PeriodicalIF":0.7000,"publicationDate":"2023-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Moscow University Chemistry Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.3103/S0027131423020050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Low molecular weight RGD peptides and RGD mimetics are widely studied as ligands targeting the corresponding receptor in the diagnosis and therapy of cancer, as well as in the field of bone tissue regeneration. Some of them are undergoing preclinical trials. The aim of this study is to select the optimal variants of the ligand structure based on an aliphatic RGD mimetic. By methods of molecular modeling (blind docking and active site docking), the most advantageous constructions for the formation of a stable complex with the integrin αVβ3 are determined. A scheme is developed and two lipotripeptides Gnd-GABA-Gly-Asp(C16)2 and Gnd-β-Ala-Gly-Asp(C16)2 with the potential ability to inhibit this receptor on the surface of tumor tissues are synthesized.

Abstract Image

低分子量靶向配体与合成具有潜在抑制整合素αVβ3能力的脂三肽的相互作用建模
低分子量RGD肽和RGD模拟物作为靶向相应受体的配体在癌症的诊断和治疗以及骨组织再生领域得到了广泛的研究。其中一些正在进行临床前试验。本研究的目的是选择基于脂肪族RGD模拟的配体结构的最佳变体。通过分子模拟(盲对接和活性位点对接)的方法,确定了与整合素αVβ3形成稳定配合物的最有利结构。我们提出了一种方案,合成了两个具有抑制肿瘤组织表面该受体的潜在能力的脂三肽Gnd- gaba - gly - asp (C16)2和Gnd-β-Ala-Gly-Asp(C16)2。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Moscow University Chemistry Bulletin
Moscow University Chemistry Bulletin CHEMISTRY, MULTIDISCIPLINARY-
CiteScore
1.30
自引率
14.30%
发文量
38
期刊介绍: Moscow University Chemistry Bulletin is a journal that publishes review articles, original research articles, and short communications on various areas of basic and applied research in chemistry, including medical chemistry and pharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信